2024
Nonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes
Son M, Riley L, Staniczenko A, Cron J, Yen S, Thomas C, Sholle E, Osborne L, Lipkind H. Nonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes. JAMA Network Open 2024, 7: e2419268. PMID: 38976271, PMCID: PMC11231799, DOI: 10.1001/jamanetworkopen.2024.19268.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusNeonatal intensive care unitPreterm birthWeeks gestationRisk of HDPPerinatal outcomesLogistic regression modelsIncreased riskPregnant individualsPrenatal vaccinationSmall-for-gestational age birth weightNeonatal intensive care unit admissionCohort studyIncreased risk of PTBOdds ratioIncreased risk of HDPRisk of preterm birthRespiratory syncytial virus seasonRespiratory syncytial virus vaccineRetrospective observational cohort studyNeonatal respiratory distressVaccination statusMultivariate logistic regression modelObservational cohort studyCox regression models
2014
Utility of cell salvage in women undergoing abdominal myomectomy
Son M, Evanko JC, Mongero LB, Lewin SN, Lu YS, Herzog TJ, Kim JH, Wright JD. Utility of cell salvage in women undergoing abdominal myomectomy. American Journal Of Obstetrics And Gynecology 2014, 211: 28.e1-28.e8. PMID: 24565686, DOI: 10.1016/j.ajog.2014.02.020.Peer-Reviewed Original ResearchConceptsCell-salvaged bloodCell salvage systemAbdominal myomectomyWeeks of gestationCell salvageUterine sizeIntraoperative blood lossLarge uterine sizeCell salvage deviceSalvage systemClinical characteristicsBlood lossAutologous bloodInfertility specialistsMultivariable modelMyomectomyHigh incidenceRoutine useReinfusionBloodWomenSalvagePatientsGestationSignificant reduction